-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Spectrum Pharmaceuticals Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2022.
- Spectrum Pharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000, a 100% decline year-over-year.
- Spectrum Pharmaceuticals Inc Income Tax Expense (Benefit) for the twelve months ending March 31, 2023 was $30K, a 11.1% increase year-over-year.
- Spectrum Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2022 was $46K, a 1050% increase from 2021.
- Spectrum Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2021 was $4K.
- Spectrum Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2020 was -$60K, a 99.3% increase from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)